Congress pushes out BIOSECURE Act deadlines to 2032, WuXi denies transfer of IP
Via Reuters (May 10), this update to the BIOSECURE Act:
A new version of a congressional bill that would restrict U.S. business with certain Chinese biotechnology companies including WuXi AppTec and BGI would give U.S. companies until 2032 to end work with the firms, extending the amount of time to find new partners.
The latest Biosecure Act also adds WuXi Biologics, opens new tab to a list of biotech companies of concern, according to a copy seen by Reuters. The other companies on the list are BGI... Читать дальше...